Client News
Filter by:
- Jan 11 2019 Endonovo Therapeutics Issues Shareholder Letter and Update
- Jan 8 2019 ClearSign and Anthony DiGiandomenico Reach Agreement to Refresh ClearSign's Board and Ensure Smooth Management Transition
- Jan 3 2019 Endonovo Therapeutics Enters into $10 million Common Stock Purchase Agreement with Azure Capital
- Dec 21 2018 CytRx Corporation Announces Conclusion of Pre-Clinical Phase for Its Albumin Binding Ultra High Potency LADR™ Drug Candidates and Accompanying Companion Diagnostic
- Dec 20 2018 ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
- Dec 18 2018 Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
- Dec 10 2018 Diego Pellicer - Colorado Announces Second Record-Breaking Sales Year on the Heels of Two National Cannabis Business Awards
- Dec 6 2018 Diego Pellicer Receives National Honors for the "Most Valuable Brand of the Year" and the "Best Retail Center" at the 2018 National Cannabis Business Awards
- Dec 6 2018 MusclePharm Enters Into Equity Exchange Agreement With American Media Valuing Company at $105 Million
- Dec 3 2018 Vitality Biopharma to Present at the 11th Annual LD Micro Main Event